Financial intelligence for Asia's healthcare markets
 
 
Remember me:

HIAS: How to adapt healthcare to an ageing population

The much-quoted figure that 25% of the population of Singapore is going to be over 65 within the next decade was the starting point at the “how to adapt healthcare to an ageing population” session at the HealthInvestor Asia Summit at the Marina Bay Sands in Singapore.

Jude Uzonwanne, principal, strategy & transaction advisory, Asia-Pacific, IQVIA, asked the two questions: how can companies profit from these changes but also how can you create the right eco-system.  

Rhenu Bhuller, partner & SVP, transformational health, Asia-Pacific, Frost & Sullivan, advised that startups should both follow the money and be passionate. “I need to ask how will that solution get funded?” she said. Many want governments to be the backbone, but the question needs to be put about where should the money flow be. “Is it from the people using it? From the family? From funds?” She said.

Omar Aziz, associate partner, Solidiance, wondered how existing players should respond to disruption. “Look at digital and technology,” he said. He pointed out although regulations are outdated, government needs to provide the catalyst so that players can come in. To reduce the cost for government, he reckoned that Blockchain was the answer. “It doesn’t need an overhaul of every system. Blockchain can sit on top and can communicate with different departments. Then at a country level, it can be used for a national database,” he added.

Mike Griffiths, regional director – healthcare, Howden Group, threw out a challenge to the insurance industry. “The insurance world in current form doesn’t have any effective solution for problems of an ageing population,” he said adding that to acquire insurance against chronic disease is virtually impossible until there is consumer demand.

The answer, said Bhuller is business model innovation. She pointed out that in Singapore, 75% of funding needs to come from family or the individual. “In ageing populations it is about asking what is important for them. It is about understanding the needs of part of that population,” she concluded.  

Posted on: 15/05/2018 UTC+08:00


News

“Asia is going through change that is unprecedented,” said Abrar Mir, managing partner, Quadria Capital, delivering the opening keynote speech at this year’s HealthInvestor Asia Summit at the Marina Bay Sands in Singapore.
Hong Kong-based Union Bridge intends to acquire an 85% stake in Beijing Yi Du Bai Shan Management. Financial terms have not been disclosed.
X-ZELL chief executive Sebastian Bhakdi reflected on the opportunities and challenges biotechnology start-ups face in Asia and why so many of them fail to go all the way from ideation to product launch at this year’s HealthInvestor Asia Summit at the Marina Bay Sands in Singapore.
Shares in Hermina Hospital Group, a private obstetrics and paediatrics group in Indonesia, dropped almost 25% on their debut today.
Despite all of the conversations about patient-centric technology, James Kilmister, development director at Civica, and chairman of the panel on “How tech and digitalisation can enhance operational efficiency and patient outcomes” cut straight to the heart of the matter. “How do you get it into organisations?” he asked.
The much-quoted figure that 25% of the population of Singapore is going to be over 65 within the next decade was the starting point at the “how to adapt healthcare to an ageing population” session at the HealthInvestor Asia Summit at the Marina Bay Sands in Singapore.
Healthcare on the SGX is focussed on 30 companies with US$25 billion in value most of which have an Asia Pacific focus, said Geoff Howie, director – equities & fixed income, Singapore Exchange, speaking at this year’s HealthInvestor Asia Summit at the Marina Bay Sands in Singapore.
That there has been a shift away from the debt capital markets (DCM), was one of the takeaways from the “Healthcare and capital markets” session at this year’s HealthInvestor Asia Summit at the Marina Bay Sands in Singapore.



Analysis

The Asia-Pacific (APAC) healthcare industry is undergoing rapid transformation with a dramatic shift in consumer behaviour and expectations, opening up growth opportunities across diagnostics, regenerative medicine, medical tourism and digital health.
Tan Chorh Chuan, executive director at the Office for Healthcare Transformation and chief health scientist at the Ministry of Health in Singapore, explains why population health improvement has to become a crucial area of focus.
What an earth happened to Ping An Good Doctor? It was expected to be one of the brightest IPOs of the year and at HK$8.8 billion (US$1.1 billion) certainly one of the biggest out of Asia Pacific.
From aspirin to bone broths, the consumer healthcare market in Asia combines East and West and the growing population has more money to spend on healthy lifestyles. Sumit Sharma, head of health & life sciences, Asia Pacific, at Oliver Wyman, looks at how to identify new sources of value.
Fabian Boegershausen, manager at corporate strategy consulting firm Solidiance, takes a look at rising healthcare costs in ASEAN and provides measurable solutions to overcome future challenges.
Bain & Company’s seventh Global Healthcare Private Equity and Corporate M&A Report shows that Asia Pacific deals last year surged to their highest levels since 2001.
In an otherwise saturated consumer health market, Matt Zafra, engagement manager, health & life sciences, Oliver Wyman, explains how traditional Chinese medicine (TCM) could form an integral part of the fabric in the goal of improving healthcare access.
In Vietnam, population and GDP growth have encouraged the country to think beyond technology in providing more health for more people.
my images

Podcasts

HealthInvestor Asia twitter feed